Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $463.81 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $168.49 | 3 | $0 (2024) |
| BioMarin Pharmaceutical Inc. | $102.86 | 2 | $0 (2023) |
| Ascendis Pharma Inc | $87.52 | 3 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $38.14 | 1 | $0 (2022) |
| Kyowa Kirin, Inc. | $29.45 | 1 | $0 (2024) |
| Eton Pharmaceuticals, Inc. | $24.01 | 1 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $13.34 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $201.07 | 4 | Novo Nordisk Inc ($145.45) |
| 2023 | $201.56 | 6 | BioMarin Pharmaceutical Inc. ($102.86) |
| 2022 | $61.18 | 2 | TOLMAR Pharmaceuticals, Inc. ($38.14) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Obesity | ||||||
| 05/03/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 03/14/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: Endocrinology | ||||||
| 01/26/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 10/26/2023 | Ascendis Pharma Inc | SKYTROFA (Drug) | Food and Beverage | In-kind items and services | $33.22 | General |
| Category: Endocrinology | ||||||
| 09/21/2023 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Biological) | Food and Beverage | In-kind items and services | $78.63 | General |
| Category: Achondroplasia | ||||||
| 08/16/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/29/2023 | Ascendis Pharma Inc | SKYTROFA (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Endocrinology | ||||||
| 06/28/2023 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Biological) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Achondroplasia | ||||||
| 04/21/2023 | Eton Pharmaceuticals, Inc. | ALKINDI (Drug) | Food and Beverage | Cash or cash equivalent | $24.01 | General |
| Category: Endocrinology | ||||||
| 10/12/2022 | TOLMAR Pharmaceuticals, Inc. | FENSOLVI (Drug) | Food and Beverage | In-kind items and services | $38.14 | General |
| Category: Central Precocious Puberty (CPP) | ||||||
| 09/21/2022 | Novo Nordisk Inc | Norditropin (Biological) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Growth Hormone | ||||||
About Madalin Berra
Madalin Berra is a Pediatric Endocrinology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/18/2019. The National Provider Identifier (NPI) number assigned to this provider is 1649739749.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Madalin Berra has received a total of $463.81 in payments from pharmaceutical and medical device companies, with $201.07 received in 2024. These payments were reported across 12 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($463.81).
Practice Information
- Specialty Pediatric Endocrinology
- Other Specialties Pediatrics, Pediatric Endocrinology
- Location Chicago, IL
- Active Since 03/18/2019
- Last Updated 10/17/2025
- Taxonomy Code 2080P0205X
- Entity Type Individual
- NPI Number 1649739749
Products in Payments
- VOXZOGO 1.2mg (Biological) $102.86
- SKYTROFA (Drug) $61.35
- FENSOLVI (Drug) $38.14
- Crysvita (Drug) $29.45
- Skytrofa (Drug) $26.17
- ALKINDI (Drug) $24.01
- Norditropin (Biological) $23.04
- Wegovy (Drug) $20.45
- TZIELD (Biological) $13.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Endocrinology Doctors in Chicago
Anita Swamy, M.d, M.D
Pediatric Endocrinology — Payments: $1.4M
Dr. Stelios Mantis, Md, MD
Pediatric Endocrinology — Payments: $40,317
Dr. Siri Atma Greeley, Md, Phd, MD, PHD
Pediatric Endocrinology — Payments: $15,340
Jennifer Miller, Md, MD
Pediatric Endocrinology — Payments: $4,695
Dr. Reema Habiby, M.d, M.D
Pediatric Endocrinology — Payments: $4,571
Dr. Courtney Finlayson, Md, MD
Pediatric Endocrinology — Payments: $4,566